View of CARDIOPROTECTIVE MECHANISMS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ISCHEMIC HEART DISEASE

Return to Issue Details CARDIOPROTECTIVE MECHANISMS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ISCHEMIC HEART DISEASE Download Download PDF